CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Open-market sale Chief Financial Officer sold 1,069 shares at $5.93 ($6,339)
- 4 Open-market buy Director bought 1,700 shares at $5.51 ($9,367)
- 4 Exercise or conversion Chief Financial Officer acquired 10,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
- 4 Open-market buy Director bought 5,438 shares at an average $5.31 ($28,874)
- 4 Open-market sale President and CEO sold 25,000 shares at $20.00 ($500,000)
- 4 Open-market sale Chief Financial Officer sold 1,082 shares at $17.87 ($19,335)
- 4 Open-market sale Chief Commercial Officer sold 1,027 shares at an average $17.89 ($18,372)
- 4 Open-market sale General Counsel sold 1,082 shares at an average $17.88 ($19,350)
- 4 Open-market sale President and CEO sold 2,940 shares at $17.87 ($52,538)
- 4 Open-market sale President and CEO sold 50,000 shares at $20.59 ($1,029,500)
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 1,011 shares at $18.05 ($18,249)
- 4 Open-market sale Chief Financial Officer sold 1,065 shares at $18.05 ($19,223)
- 4 Grant or award Director acquired 5,600 shares (grant or award)
- 4 Open-market sale President and CEO sold 2,523 shares at $18.05 ($45,540)
- 4 Open-market sale General Counsel sold 1,065 shares at $18.05 ($19,223)
Page 7 of 12 · 229 filings